DK199900435U3 - Farmaceutisk præparat omfattende paroxetin-methansulfonat samt anvendelse heraf - Google Patents

Farmaceutisk præparat omfattende paroxetin-methansulfonat samt anvendelse heraf

Info

Publication number
DK199900435U3
DK199900435U3 DK199900435U DKBA199900435U DK199900435U3 DK 199900435 U3 DK199900435 U3 DK 199900435U3 DK 199900435 U DK199900435 U DK 199900435U DK BA199900435 U DKBA199900435 U DK BA199900435U DK 199900435 U3 DK199900435 U3 DK 199900435U3
Authority
DK
Denmark
Prior art keywords
pharmaceutical preparation
paroxetine methanesulfonate
paroxetine
methanesulfonate
pharmaceutical
Prior art date
Application number
DK199900435U
Other languages
English (en)
Inventor
David Philip Elder
Ahmad Khalaf Al Deeb A Ghazawi
Padma Meneaud
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9914601.1A external-priority patent/GB9914601D0/en
Priority claimed from GBGB9914709.2A external-priority patent/GB9914709D0/en
Priority claimed from GBGB9927501.8A external-priority patent/GB9927501D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of DK199900435U3 publication Critical patent/DK199900435U3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK199900435U 1999-06-22 1999-12-03 Farmaceutisk præparat omfattende paroxetin-methansulfonat samt anvendelse heraf DK199900435U3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9914601.1A GB9914601D0 (en) 1999-06-22 1999-06-22 Composition
GBGB9914709.2A GB9914709D0 (en) 1999-06-23 1999-06-23 Composition
GBGB9927501.8A GB9927501D0 (en) 1999-11-19 1999-11-19 Composition

Publications (1)

Publication Number Publication Date
DK199900435U3 true DK199900435U3 (da) 2000-02-11

Family

ID=27269749

Family Applications (2)

Application Number Title Priority Date Filing Date
DK199901730A DK199901730A (da) 1999-06-22 1999-12-03 Ny Sammensætning
DK199900435U DK199900435U3 (da) 1999-06-22 1999-12-03 Farmaceutisk præparat omfattende paroxetin-methansulfonat samt anvendelse heraf

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK199901730A DK199901730A (da) 1999-06-22 1999-12-03 Ny Sammensætning

Country Status (21)

Country Link
EP (1) EP1064936A1 (da)
AT (1) AT3722U1 (da)
AU (2) AU1573100A (da)
BE (2) BE1013166A6 (da)
CA (1) CA2291542A1 (da)
CH (1) CH690024A5 (da)
DE (2) DE19958228A1 (da)
DK (2) DK199901730A (da)
ES (1) ES2159260B1 (da)
FI (2) FI4488U1 (da)
FR (1) FR2795327A1 (da)
GB (1) GB2351233A (da)
GR (1) GR1003490B (da)
IE (2) IES991108A2 (da)
IT (1) ITMI992549A1 (da)
LU (1) LU90483B1 (da)
NL (2) NL1013750C1 (da)
NO (1) NO995945L (da)
PT (1) PT102384A (da)
SE (1) SE9904404L (da)
WO (1) WO2000078291A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
HUP0303827A2 (hu) * 2000-08-28 2004-04-28 Synthon B.V. Paroxetinkészítmények és eljárások ezek előállítására
US6921839B2 (en) 2000-08-29 2005-07-26 Ranbaxy Laboratories Limited Synthesis of N,N-dimethyl-3-(4-methyl) benzoyl propionamide a key intermediate of zolpidem
DE20100529U1 (de) * 2001-01-11 2001-05-10 Synthon Bv Pharmazeutische Tablette umfassend Paroxetinmesylat
CA2361882A1 (en) * 2001-10-19 2003-04-19 Bernard Charles Sherman Liquid for oral administration comprising paroxetine
EP1469829B1 (en) 2002-02-01 2016-01-27 Bend Research, Inc Immediate release dosage forms containing solid drug dispersions
WO2005010002A1 (en) * 2003-07-31 2005-02-03 Ranbaxy Laboratories Limited Process for the synthesis of zolpidem
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
CN105963273A (zh) * 2016-05-02 2016-09-28 杭州富阳伟文环保科技有限公司 甲磺酸帕罗西汀胶囊及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992009281A2 (en) * 1990-11-24 1992-06-11 Beecham Group Plc Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation
GB9605828D0 (en) * 1996-03-20 1996-05-22 Smithkline Beecham Plc Treatment method
AU3108097A (en) * 1997-06-10 1998-12-30 Synthon B.V. 4-phenylpiperidine compounds
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.

Also Published As

Publication number Publication date
EP1064936A1 (en) 2001-01-03
SE9904404L (sv) 2000-12-23
ES2159260A1 (es) 2001-09-16
AT3722U1 (de) 2000-07-25
FR2795327A1 (fr) 2000-12-29
DE29921300U1 (de) 2000-02-10
AU1573100A (en) 2001-01-09
FI19992609A (fi) 2000-12-22
SE9904404D0 (sv) 1999-12-03
GB9928673D0 (en) 2000-02-02
ES2159260B1 (es) 2002-05-01
CA2291542A1 (en) 2000-12-22
LU90483B1 (fr) 2001-01-31
WO2000078291A1 (en) 2000-12-28
PT102384A (pt) 2000-12-29
IES991108A2 (en) 2001-04-04
NO995945L (no) 2000-12-27
FIU990494U0 (fi) 1999-12-03
BE1013166A6 (fr) 2001-10-02
AU727000B3 (en) 2000-11-30
DK199901730A (da) 2000-12-23
FI4488U1 (fi) 2000-07-20
ITMI992549A1 (it) 2001-06-03
NL1013750C1 (nl) 2000-12-28
DE19958228A1 (de) 2000-12-28
GB2351233A (en) 2000-12-27
IE991107A1 (en) 2001-05-30
NL1013749C2 (nl) 2001-01-08
BE1012806A3 (fr) 2001-03-06
CH690024A5 (fr) 2000-03-31
NO995945D0 (no) 1999-12-03
GR1003490B (el) 2000-11-30
ITMI992549A0 (it) 1999-12-03

Similar Documents

Publication Publication Date Title
FI991485A0 (fi) Uusi farmaseuttinen koostumus
NO20012915L (no) Ny farmasöytisk formulering
DK1128831T3 (da) Farmaceutisk moxifloxacinpræparat
NO20015175D0 (no) Farmasöytisk sammensetning
ITTO20010008A0 (it) Formulazione farmaceutica
NO20022970L (no) Hydrogel-drevet medikamentdoseringsform
DE69812089D1 (de) Pharmazeutische omeprazol-formulierung
FI20012462A (fi) Farmaseuttisia formulaatioita ja menetelmiä käsittäen intranasaalista morfiinia
FI4823U1 (fi) Muunnetulla tavalla vapauttava lääkeformulaatio
NO20005399L (no) Farmasöytisk preparat
DK1466615T3 (da) Farmaceutisk præparat
NO20015149D0 (no) Nytt farmasöytisk preparat
NO20015670L (no) Forbedrede farmasöytiske formuleringer
PT1230230E (pt) Derivados de indeno-di-hidrotiazole sua preparacao e sua utilizacao como medicamentos anorexigenico
NO20022606D0 (no) Farmasöytiske kombinasjoner
ATE383868T1 (de) Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka
NO20015148D0 (no) Nytt farmasöytisk preparat
DK199900435U3 (da) Farmaceutisk præparat omfattende paroxetin-methansulfonat samt anvendelse heraf
NO20022022L (no) N-guanidinoalkylamider, deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse
ID30032A (id) Formulasi farmasi
NO20015104D0 (no) Nytt farmasöytisk preparat
AR025867A1 (es) Formulacion portasdora farmaceutica
IS6163A (is) Lyfjakomplex
NO20014692D0 (no) 3-amidinobenzensulfonamidderivater, medisinske sammensetninger inneholdende slike samt intermediater vedfremstillingen derav
NO20015105D0 (no) Nytt farmasöytisk preparat